According to the Kaplan‒Meier survival curves, breast cancer patients with high PTK2 expression exhibited poor overall survival (OS) (Figure 3A), but disease-specific survival (DSS) and progression-free interval (PFI) were not affected (Figures 3B,C). This evidence concerns the gene PTK2 and breast carcinoma.